Mechanopharmacology Of Cellular Microenvironment Stiffness: Therapeutic Strategies For Age-Related Diseases
As we age, our tissues undergo various changes, and one significant alteration is the stiffening of the environment surrounding our cells. Imagine your cells as tiny bricks in a building; the “mortar” holding them together, called the extracellular matrix (ECM), can become less flexible over time. This increased stiffness isn’t just a harmless side effect of aging; it profoundly impacts how our cells behave and function, contributing to the development and progression of many age-related diseases.
This stiffening is influenced by factors both inside and outside the cell, such as changes in the composition of the ECM, including increased collagen and reduced elastin. These changes affect how cells sense and respond to mechanical signals, which in turn alters crucial internal communication pathways.
For instance, in organs like the lungs and ovaries, which experience similar age-related stiffening, these mechanical changes can lead to dysfunction. Declining estrogen levels, common with aging, also play a role in promoting inflammation and fibrosis (scarring) in tissues like the lungs, further accelerating the aging process.
But there’s good news! Researchers are exploring a new field called mechanopharmacology, which focuses on developing treatments that specifically target these mechanical changes in our tissues. By understanding the common pathways and factors that drive ECM stiffness in different organs, we can develop innovative treatments. These interventions, such as hormone replacement therapies or anti-fibrotic agents, aim to restore tissue elasticity, slow down functional decline, and ultimately improve overall organ health. The goal is to address the root causes of age-related diseases, thereby enhancing both the length and quality of our lives.
Source: link to paper